Construction of Peptide-Isoquinolone Conjugates via Rh(III)-Catalyzed C-H Activation/Annulation.
Liangliang SongZhenwei LvYan LiKui ZhangErik V Van der EyckenLingchao CaiPublished in: Organic letters (2023)
Herein, we disclose a Rh(III)-catalyzed C-H activation/annulation reaction for the derivatization of Lys-based peptides, in situ affording diverse peptide-isoquinolone conjugates. This approach features racemization-free conditions, high atom- and step-economy, excellent chemo- and site-selectivity, and broad scope including substrates bearing unprotected Trp and Tyr, free Ser and Gln, and Met residues. The peptide-isoquinolone conjugates also display good fluorescent properties with maximum emission wavelengths up to 460 nm. Importantly, preliminary antifungal activity studies indicate that peptide-isoquinolone conjugates show potential activities toward crop and forest pathogenic fungi, in which the peptide-isoquinolone conjugate bearing unprotected Tyr residue exhibits much better antifungal activities toward B. cinerea Pers . and C. chrysosperma than the positive control.
Keyphrases
- cancer therapy
- climate change
- photodynamic therapy
- squamous cell carcinoma
- molecular dynamics
- risk assessment
- room temperature
- mass spectrometry
- high resolution
- tyrosine kinase
- liquid chromatography
- quantum dots
- amino acid
- ms ms
- tandem mass spectrometry
- candida albicans
- gas chromatography
- locally advanced
- high performance liquid chromatography